Antitumor activity of cytokine-induced killer cells against human lung cancer

International Immunopharmacology

Volumn 7, Issue 13, 2007, Pages 1802-1807

  Kim, Hwan Mook ^a   Lim, Jaeseung ^b   Park, Song Kyu ^a   Kang, Jong Soon ^a   Lee, Kiho ^a   Lee, Chang Woo ^a   Lee, Ki Hoon ^a   Yun, Mi Jung ^b   Yang, Kyu Hwan ^c   Han, Gyoonhee ^d   Kwon, Soon Woo ^e   Kim, Youngsoo ^e   Han, Sang Bae ^e  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Innocell Ltd   (South Korea)

^c Gachon University   (South Korea)

^d Yonsei University   (South Korea)

^e Chungbuk National University   (South Korea)

Author keywords

Adoptive immunotherapy; Cytokine induced killer cells; Lung cancer

Indexed keywords

CD3 ANTIBODY; CD3 ANTIGEN; CD56 ANTIGEN; CHROMIUM 51; CYTOKINE; INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL THERAPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KILLER CELL; LUNG CANCER; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD56; CELL LINE, TUMOR; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS; LUNG NEOPLASMS; MICE;

EID: 35848940733     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.08.016     Document Type: Article

References (28)

1. Kalinski P., Nakamura Y., Watchmaker P., Giermasz A., Muthuswamy R., and Mailliard R.B. Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines. Immunol Res 36 (2006) 137-146
2. Takashima K., Fujiwara H., Inada S., Atsuji K., Araki Y., Kubota T., et al. Tracking of green fluorescent protein (GFP)-labeled LAK cells in mice carrying B16 melanoma metastases. Anticancer Res 26 (2006) 3327-3332
3. Raja Gabaglia C., Diaz de Durana Y., Graham F.L., Gauldie J., Sercarz E.E., and Braciak T.A. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors. Cancer Res 67 (2007) 2290-2297
4. Wang W., Epler J., Salazar L.G., and Riddell S.R. Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1. Cancer Res 66 (2006) 6826-6833
5. Thorne S.H., Negrin R.S., and Contag C.H. Synergistic antitumor effects of immune cell-viral biotherapy. Science 311 (2006) 1780-1784
6. Alvarnas J.C., Linn Y.C., Hope E.G., and Negrin R.S. Expansion of cytotoxic CD3+CD56+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 7 (2001) 216-222
7. Lu P.H., and Negrin R.S. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 153 (1994) 1687-1696
8. Baker J., Verneris M.R., Ito M., Shizuru J.A., and Negrin R.S. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood 97 (2001) 2923-2931
9. Han S.B., Lee C.W., Yoon Y.D., Kang J.S., Lee K.H., Yoon W.K., et al. Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A. Biochem Pharmacol 70 (2005) 1518-1526
10. Leemhuis T., Wells S., Scheffold C., Edinger M., and Negrin R.S. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. Biol Blood Marrow Transplant 11 (2005) 181-187
11. Takayama T., Sekine T., Makuuchi M., Yamasaki S., Kosuge T., Yamamoto J., et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356 (2000) 802-807
12. Kornacker M., Moldenhauer G., Herbst M., Weilguni E., Tita-Nwa F., Harter C., et al. Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma. Int J Cancer 119 (2006) 1377-1382
13. Sun S., Li X.M., Li X.D., and Yang W.S. Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines. Cancer Biother Radiopharm 20 (2005) 173-180
14. Han S.B., Moratz C., Huang N.N., Kelsall B., Cho H., Shi C.S., et al. Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles. Immunity 22 (2005) 343-354
15. Verneris M.R., Arshi A., Edinger M., Kornacker M., Natkunam Y., Karami M., et al. Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. Clin Cancer Res 11 (2005) 4561-4570
16. Han S.B., Lee C.W., Jeon Y.J., Hong N.D., Yoo I.D., Yang K.H., et al. The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 41 (1999) 157-164
17. Kim J.Y., Yoon Y.D., Ahn J.M., Kang J.S., Park S.K., Lee K., et al. Angelan isolated from Angelica gigas Nakai induces dendritic cell maturation through toll-like receptor 4. Int Immunopharmacol 7 (2007) 78-87
18. Park M.S., Chang Y.S., Shin J.H., Kim D.J., Chung K.Y., Shin D.H., et al. The prevalence of human papillomavirus infection in Korean non-small cell lung cancer patients. Yonsei Med J 48 (2007) 69-77
19. Tsai J.R., Chong I.W., Chen Y.H., Yang M.J., Sheu C.C., Chang H.C., et al. Differential expression profile of MAGE family in non-small-cell lung cancer. Lung Cancer 56 (2007) 185-192
20. Ruttinger D., Winter H., van den Engel N.K., Hatz R.A., Schlemmer M., Pohla H., et al. Immunotherapy of lung cancer: an update. Onkologie 29 (2006) 33-38
21. Stinchcombe T.E., Lee C.B., and Socinski M.A. Current approaches to advanced-stage non-small-cell lung cancer: first-line therapy in patients with a good functional status. Clin Lung Cancer 7 Suppl 4 (2006) S111-S117
22. Wakabayashi O., Yamazaki K., Oizumi S., Hommura F., Kinoshita I., Ogura S., et al. CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 94 (2003) 1003-1009
23. Lipson S.D., Chretien P.B., Makuch R., Kenady D.E., and Cohen M.H. Thymosin immunotherapy in patients with small cell carcinoma of the lung: correlation of in vitro studies with clinical course. Cancer 43 (1979) 863-870
24. Raez L.E., Fein S., and Podack E.R. Lung cancer immunotherapy. Clin Med Res 3 (2005) 221-228
25. Clamon G., Herndon J., Kern J., Govindan R., Garst J., Watson D., et al. Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B. Cancer 103 (2005) 1670-1675
26. Hanibuchi M., Yano S., Nishioka Y., Yanagawa H., Kawano T., and Sone S. Therapeutic efficacy of mouse-human chimeric anti-ganglioside GM2 monoclonal antibody against multiple organ micrometastases of human lung cancer in NK cell-depleted SCID mice. Int J Cancer 78 (1998) 480-485
27. Hirschowitz E.A., Foody T., Kryscio R., Dickson L., Sturgill J., and Yannelli J. Autologous dendritic cell vaccines for non-small-cell lung cancer. J Clin Oncol 22 (2004) 2808-2815
28. Motohashi S. Translational research in patients with lung cancer-clinical application of NKT cell immunotherapy. Gan To Kagaku Ryoho 34 (2007) 550-553